These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 114650)

  • 1. In vitro binding and pharmacokinetics of gold salts in plasma proteins and chelating agents.
    Biggs DF; Boland DM; Davis P; Wakaruk J
    J Rheumatol Suppl; 1979; 5():68-73. PubMed ID: 114650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance.
    Iqbal MS; Taqi SG; Arif M; Wasim M; Sher M
    Biol Trace Elem Res; 2009 Sep; 130(3):204-9. PubMed ID: 19194667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein binding of gold in serum of patients treated with different gold preparations].
    Herrlinger JD; Weikert W
    Z Rheumatol; 1982; 41(5):230-4. PubMed ID: 6818790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of gold in biological tissue. A photochemical method for light and electronmicroscopy.
    Danscher G
    Histochemistry; 1981; 71(1):81-8. PubMed ID: 6785260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of parenteral and oral gold compounds.
    Gottlieb NL
    J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 7. Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.
    Jellum E; Munthe E; Guldal G; Aaseth J
    Ann Rheum Dis; 1980 Apr; 39(2):155-8. PubMed ID: 6770766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1980; 7(6):820-4. PubMed ID: 6782245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface.
    Okada T; Patterson BK; Ye SQ; Gurney ME
    Virology; 1993 Feb; 192(2):631-42. PubMed ID: 8421903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of auranofin in animals.
    Intoccia AP; Flanagan TL; Walz DT; Gutzait L; Swagzdis JE; Flagiello J; Hwang BY; Dewey RH; Noguchi H
    J Rheumatol Suppl; 1982; 8():90-8. PubMed ID: 6813497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of myelopoiesis by gold salts and D-penicillamine.
    Hamilton JA; Williams N
    J Rheumatol; 1985 Oct; 12(5):892-6. PubMed ID: 3936930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of gold sodium thiomalate.
    Waller ES; Massarella JW; Crout JE; Yakatan GJ
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):33-47. PubMed ID: 6812186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of two gold compounds on lysosomes.
    Graabaek PM; Pedersen SM
    Ann Rheum Dis; 1988 Jun; 47(6):509-14. PubMed ID: 3132900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracellular gold content of circulating blood cells using various gold compounds].
    Herrlinger JD; Beress R; Hecker U
    Wien Klin Wochenschr Suppl; 1984; 156():13-6. PubMed ID: 6442048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated administration of chelating agents on distribution, excretion, and renal toxicity of gold sodium thiomalate in rats.
    Takahashi Y; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):253-6. PubMed ID: 1604050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.